Table 8.
No. | Discovered Activity, (Pa) * | Reported Activity | Ref. |
---|---|---|---|
79 | Antihypercholesterolemic (0.964) Atherosclerosis treatment (0.717) |
Activity not studied | |
80 | Antihypercholesterolemic (0.956) | Activity not studied | |
81 | Antihypercholesterolemic (0.989) Hypolipemic (0.808) |
Activity not studied | |
82 | Antihypercholesterolemic (0.960) Atherosclerosis treatment (0.683) |
Activity not studied | |
83 | Antihypercholesterolemic (0.961) Cholesterol synthesis inhibitor (0.745) |
Activity not studied | |
84 | Antihypercholesterolemic (0.956) Cholesterol synthesis inhibitor (0.747) |
Activity not studied | |
85 | Antihypercholesterolemic (0.964) | Activity not studied | |
86 | Antihypercholesterolemic (0.969) | Activity not studied | |
87 | Antihypercholesterolemic (0.952) Atherosclerosis treatment (0.710) |
Activity not studied | |
88 | Antihypercholesterolemic (0.965) Atherosclerosis treatment (0.677) |
Activity not studied | |
89 | Antihypercholesterolemic (0.969) | Activity not studied | |
90 | Antihypercholesterolemic (0.965) Atherosclerosis treatment (0.700) |
Activity not studied | |
91 | Antihypercholesterolemic (0.969) | Activity not studied | |
92 | Antihypercholesterolemic (0.962) Atherosclerosis treatment (0.704) Lipid metabolism regulator (0.702) |
Activity not studied | |
93 | Antihypercholesterolemic (0.974) Antimicrobial treatment (0.717) |
Antimicrobial | [237] |
94 | Antihypercholesterolemic (0.961) Antineoplastic (0.863) Anticarcinogenic (0.828) Lipid metabolism regulator (0.747) Antimetastatic (0.590) |
Anticancer | [238,239] |
95 | Antihypercholesterolemic (0.936) Antineoplastic (0.870) Anticarcinogenic (0.807) Antimetastatic (0.598) |
Anticancer | [238,239] |
* Only activities with Pa > 0.5 are shown.